Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice.

Miwao Matsumoto,M. Sata,D. Fukuda,Kimie Tanaka,M. Soma,Y. Hirata,R. Nagai
DOI: https://doi.org/10.1016/J.ATHEROSCLEROSIS.2007.07.023
IF: 5.3
2008-04-01
Atherosclerosis
Abstract:
What problem does this paper attempt to address?